 First time in human |
| Pharmacokinetics |
| Pharmacodynamics |
| Bioavailability |
| Bioequivalence |
| Drug interaction |
| Genotyping |
| Food effects |
| Safety and tolerability |
| Age/gender |
| Single and multiple dose escalation with on-line PK analysis |
| Special populations |
| Skin irritation and sensitization studies |
| New dose forms |
| Medical device |
| Vaccines |
 |
||
 |
In Phase I / Bioequivalence PharmaNet offers a comprehensive range of clinical development and consulting services for early stage programs, including Phase I and bioequivalence studies. PharmaNet conducts early stage programs for international sponsors through our global network of resources. |
 |
 |
||
Experience
PharmaNet Development Group, Inc.
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
© 2008 PharmaNet Development Group, Inc. All rights reserved.